As a tumor suppressor gene, the lost or mutation of PTEN was revealed and regarded as diagnostic biomarker in multiple types of cancers, like prostate cancer [23], breast cancer [24], gastric cancer [25], cervical carcinoma [26], and EC [27, 28]. This evidence concerns the gene PTEN and breast carcinoma.